Search Results 1451-1460 of 16344 for monoclonal antibody

1. Neurology - Clinical trials

   The purpose of this study is to determine the prevalence, diagnostic accuracy and predictors of antinueronal antibody positivity in serum and cerebrospinal ...

2. Research Themes and Focus Groups - Mayo Clinic Research

   These themes are organized to follow a classic cell signaling cascade from the plasma membrane to nuclear events: Cellular networks. About 37% of our ...

3. A Study to Evaluate Regional Radiotherapy in Biomarker Low-Risk Node Positive Breast Cancer - Mayo Clinic

   The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...

4. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

   Positive test result at screening for hepatitis B surface antigen (HBsAg) or anti-human immunodeficiency virus antibody (HIV Ab). HCV genotype performed ...

5. Discovery's Edge: Cleaning up cancer - Mayo Clinic News Network

   ... antibody to guide an established cancer drug to melanoma tumors. Dr. Markovic, whose background is biochemistry, packs several hundred of these antibodies ...

6. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

   ... antibodies or anti-MOG antibodies) 20. Diagnosis of progressive multifocal leukoencephalopathy (PML) Exclusion Criteria Specific to PD Subjects: 21 ...

7. A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer - Mayo Clinic

   Prior therapy with any of the following: PD-1, PD-L1, CTLA4 antibody, or any other drug targeting T cell checkpoint pathways. ... antibodies or infused ...

8. Belimumab in Remission of VASculitis - Mayo Clinic

   Tested positive for anti-proteinase 3 (anti-PR3) or anti-myeloperoxidase (anti-MPO) antibodies at any time prior to enrollment. Achieve remission no more ...

9. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Subject has received prior investigational therapy directed at BCMA including, but not limited to, bispecific T cell-engaging antibodies or molecules, antibody ...

10. Consultative resources - Center for Clinical and Translational Science

    Find consultative resources and support services for Mayo Clinic investigators and study teams at the Center for Clinical and Translational Science (CCaTS).